Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer

BACKGROUND: The addition of oxaliplatin to adjuvant 5-fluorouracil (5-FU) improves survival of patients with stage III colon cancer in randomized clinical trials (RCTs). However, RCT participants are younger, healthier, and less racially diverse than the general cancer population. Thus, the benefit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sanoff, Hanna K., Carpenter, William R., Martin, Christopher F., Sargent, Daniel J., Meyerhardt, Jeffrey A., Stürmer, Til, Fine, Jason P., Weeks, Jane, Niland, Joyce, Kahn, Katherine L., Schymura, Maria J., Schrag, Deborah
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3274510/
https://ncbi.nlm.nih.gov/pubmed/22266473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr524
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados